A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer

Theranostics. 2016 Jan 25;6(3):435-45. doi: 10.7150/thno.13896. eCollection 2016.

Abstract

Cancer metastasis is the leading reason for the high mortality of breast cancer. Herein, we report on a pH-responsive host-guest nanosystem of succinobucol (PHN) with pH-stimuli controlled drug release behavior to improve the therapeutic efficacy on lung metastasis of breast cancer. PHN was composed of the host polymer of β-cyclodextrin linked with multiple arms of N,N-diisopropylethylenediamine (βCD-DPA), the guest polymer of adamantyl end-capped methoxy poly(ethylene glycol) (mPEG-Ad), and the active agent of succinobucol. PHN comprises nanometer-sized homogenous spherical particles, and exhibits specific and rapid drug release in response to the intracellular acidic pH-stimuli. Then, the anti-metastatic efficacy of PHN is measured in metastatic 4T1 breast cancer cells, which effectively confirms the superior inhibitory effects on cell migration and invasion activities, VCAM-1 expression and cell-cell binding of RAW 264.7 to 4T1 cells. Moreover, PHN can be specifically delivered to the sites of metastatic nodules in lungs, and result in an obviously improved therapeutic efficacy on lung metastasis of breast cancer. Thereby, the pH-responsive host-guest nanosystem can be a promising drug delivery platform for effective treatment of cancer metastasis.

Keywords: Breast cancer.; Cancer metastasis; Cyclodextrin; Host-guest nanosystem; pH-responsive.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacokinetics*
  • Breast Neoplasms / complications*
  • Cell Movement / drug effects
  • Disease Models, Animal
  • Drug Delivery Systems*
  • Female
  • Hydrogen-Ion Concentration
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Mice, Inbred BALB C
  • Nanostructures / administration & dosage
  • Nanostructures / chemistry
  • Neoplasm Invasiveness
  • Polyethylene Glycols / metabolism
  • Probucol / administration & dosage
  • Probucol / analogs & derivatives*
  • Probucol / pharmacokinetics
  • Treatment Outcome
  • beta-Cyclodextrins / metabolism

Substances

  • Antineoplastic Agents
  • beta-Cyclodextrins
  • Polyethylene Glycols
  • monomethoxypolyethylene glycol
  • succinobucol
  • Probucol